5/17, 4:34 PM (Source: TeleTrader)
more TeleTrader news


Chart for: Pfizer Inc

FDA approves Pfizer boosters for 5-11 year olds

The United States Food and Drug Administration authorized on Tuesday the use of single Pfizer COVID-19 booster vaccine dose in children aged between five and 11 years for those inoculated at least five months ago.

"The FDA is authorizing the use of a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age to provide continued protection against COVID-19. Vaccination continues to be the most effective way to prevent COVID-19 and its severe consequences, and it is safe," the FDA noted.

Baha Breaking News (BBN) / ND